At the forefront of pharmaceutical innovation, Virupaksha stands as a beacon of excellence in manufacturing high-purity Fluconazole, crucial for treating severe infections like cryptococcal meningitis. With an unwavering commitment to quality and safety, the company operates under stringent WHO-GMP guidelines, ensuring that every batch produced meets international standards for efficacy and purity.
Their state-of-the-art facilities are not only ISO 9001 certified—confirming their dedication to consistent quality management—but also ISO 14001 certified, highlighting their proactive approach to environmental sustainability in production processes. This meticulous attention to detail underscores Virupaksha’s mission: delivering pharmaceuticals that healthcare professionals can trust while contributing positively to the global community’s health outcomes.
Other Latest News
- Dermal Fillers Market Forecast Indicates USD 12.41 Billion Valuation by 2033 | Coherent Market Insights June 5, 2026 12:58 pm EIN Presswire The Global Dermal Fillers Market is estimated to be valued at USD 5.72 Bn in 2026 and is expected to reach USD 12.41 Bn by 2033 BURLINGAME, CA, UNITED STATES, June 5, 2026 /EINPresswire.com/ -- The latest study, titled Dermal Fillers Market 2026 …
- Advancing Precision through Next-Generation Drug Delivery Systems June 4, 2026 5:31 pm Pharma Tech Outlook By Pharma Tech Outlook | Wednesday, April 29, 2026 Drug delivery has become the limiting factor in translating therapeutic innovation into clinical impact. Breakthroughs in gene editing, RNA therapeutics and targeted oncology continue to outpace the …
- Diversity hiring jumps 21% despite slowdown in white-collar recruitment: foundit June 4, 2026 2:54 pm The Economic Times India’s overall white-collar hiring moderated in May 2026, declining 4% year-on-year and 6% month-on-month, according to the latest foundit Insights Tracker (fit) by foundit, Asia’s leading jobs and talent platform. Against this broader slowdown, diversity …
- New Research: SQL Rivals Python as America’s Most In-Demand Programming Language – and It’s Needed Far Beyond Silicon Valley June 4, 2026 1:17 pm EIN Presswire Coding skills are increasingly mentioned across job ads in finance, healthcare, manufacturing, and other sectors. Vilnius, Lithuania, June 4, 2026. – As AI transforms the demand for worker skills across the U.S., a new analysis, conducted by Oxylabs, a web …
- <![CDATA[Pharma Pulse: 340B Uncertainty, Drug Shortages, and Wegovy's Global Debut]]> June 4, 2026 1:03 pm Pharmaceutical Commerce Welcome to Pharma Pulse, a Pharmaceutical Commerce podcast bringing you the latest insights shaping patient access, regulatory policy, and healthcare innovation. I'm your host, and let's get into today's headlines. First up, a new survey from …
- Air Quality Control Systems Market to Reach $144.09 Billion, Globally, by 2026 at 5.2% CAGR: Allied Market Research June 4, 2026 12:35 pm EIN Presswire Air Quality Control Systems Market to Reach $144.09 Billion, Globally, by 2026 at 5.2% CAGR: Allied Market Research WILMINGTON, DE, UNITED STATES, June 4, 2026 /EINPresswire.com/ -- Allied Market Research published a report, titled, "Air …
- Eli Lilly continues genetic medicine push with $1.9bn Ascidian partnership June 4, 2026 11:46 am Pharmaceutical Technology Eli Lilly has penned a research collaboration deal with Massachusetts-based biotech, Ascidian Therapeutics, to discover and develop drugs for kidney diseases – adding another bead to the string of genetic medicine-focused deals Lilly has signed over the …
- Sensex today | Stock Market Live: Stock to buy today: Olectra Greentech June 4, 2026 3:25 am The Hindu Business Line Aurobindo Pharma: Company’s arm Theranym Biologics starts biologics contract manufacturing facility. (Positive) BHEL: Company has secured international contract worth INR 2000-2500 Crores (Positive) Agarwal Industrial: Company bags HPCL bitumen supply …
- Pharma exports to US seen muted this year June 4, 2026 3:04 am ETPharma.com New Delhi: India's pharmaceutical exports to the United States are likely to remain subdued this year, weighed down by fears of adverse policy decisions, headlong price erosion in the generics space and the risk of an escalating West Asia crisis. …
- Aurobindo inaugurates CDMO-arm biologics facility in Telangana June 4, 2026 3:03 am ETPharma.com New Delhi: Aurobindo Pharma announced the the inauguration of its biologics contract manufacturing organisation, TheraNym, first plant in Telangana. The Borapatla-based facility is equipped with 15 KL bioreactors, advanced downstream processing suites, …
- Aurobindo Pharma enters biologics contract manufacturing with ₹1,200-crore Telangana facility June 3, 2026 11:00 pm ETManufacturing.in Aurobindo Pharma has launched TheraNym, a major biologics manufacturing plant in Telangana. Aurobindo Pharma has formally entered the biologics contract manufacturing business with the inauguration of TheraNym, a ₹1,200-crore facility in Telangana that …
- Highlights of ASCO 2026: how is cancer care evolving? June 3, 2026 10:16 pm Labiotech The American Society of Clinical Oncology (ASCO) conference is where the global cancer care community gather to discuss key advancements in cancer research and policy. This year, it was held from May 29 to June 2, in Chicago, Illinois. Labiotech heard from …
- Shilpa Biocare Pvt Ltd and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy June 3, 2026 9:53 pm Equity Bulls Shilpa Biocare Pvt Ltd, a wholly owned subsidiary of Shilpa Medicare Limited (BSE/NSE: SHILPAMED), a global innovative pharma company and CDMO, today announced a strategic equity partnership with Gate2Brain, S.L. ("Gate2Brain"), a …
- Medical Device Regulatory Affairs Market to Reach USD 15.94 Billion by 2035 as Global Compliance Demands Rise | SNS Insider June 3, 2026 8:14 pm Business Upturn U.S. Market Valued at USD 2.14 Billion in 2025; Europe Market Projected to Reach USD 4.38 Billion by 2035 Following EU MDR and IVDR Adoption. Austin, United States, June 03, 2026 (GLOBE NEWSWIRE) — “The Medical Device Regulatory Affairs Market size was …
- Lonza Enhances Biologics Preclinical Development Offering June 3, 2026 5:42 pm Contract Pharma Lonza has enhanced its biologics preclinical development offering designed to help customers make more confident early‑stage decisions and to accelerate timelines and reduce development risk. The offering integrates development, manufacturing, and …
- India's diversity hiring up 21% in May: Report June 3, 2026 5:12 pm ETHRWorld Diversity and inclusion (D&I) focused hiring -- which includes LGBTQIA+ and neurodiverse talent has expanded to nearly a third of all diversity hires. D&I-focused hiring has expanded to 32 per cent, particularly within IT and consulting …
- Pharmaceutical Packaging Market: Size, Trends, and Future Outlook 2026-2033 June 3, 2026 3:00 pm EIN Presswire The pharmaceutical packaging market is expanding steadily, driven by rising healthcare demand, biopharmaceutical growth, smart packaging adoption. LONDON, UNITED KINGDOM, June 3, 2026 /EINPresswire.com/ -- The global pharmaceutical packaging …
- CAM, Khaitan act on True North’s minority stake acquisition in Embio June 3, 2026 2:07 pm ETLegalWorld.com Cyril Amarchand Mangaldas has advised True North on its acquisition of a minority stake in Embio, a regulated markets-focused manufacturer of complex API and advanced intermediates, and a key player in the controlled substances sector. Khaitan & Co …
- Avammune’s big bet: Why the future of cancer treatment may come in a pill June 3, 2026 12:43 pm The Economic Times In the fight against cancer, CAR-T therapy and checkpoint inhibitors are two powerful types of immunotherapies that help the immune system fight cancer. CAR-T is like a custom-made special forces team. Doctors take a patient’s own T-cells (killer immune …
- Patient-first, America-first: The Case For Global Collaboration June 3, 2026 7:59 am LifeSciVC The rise of China in the global biopharma ecosystem has led to fear and hysteria in some corners of our ecosystem. Apparently there have been too many deals with Chinese players by both venture investors and Big Pharma. US biotech is being gutted and …
- Stocks to Watch, June 3: Infosys, Canara Bank, Vedanta, REC, Shelter Pharma, JSW Steel, Magellanic Cloud June 3, 2026 5:23 am The Hindu Business Line Corporate announcements dominated market attention as Infosys secured a strategic banking mandate, Vedanta faced regulatory scrutiny, Canara Bank approved capital raising, UPL received CCI clearance, while John Cockerill, Servotech, Advait and Magellanic …
- AI-powered cyberattacks could overwhelm enterprises within months, says Palo Alto Networks CIO Rajavel June 3, 2026 1:45 am ETTelecom.com Meerah Rajavel, chief information officer, Palo Alto Networks.Palo Alto Networks expects advanced offensive artificial intelligence capabilities to become widely accessible within four to six months, based on how quickly previous generations of AI models …
- Lysine Market to Reach US$9.7 Bn by 2033 Driven by Animal Feed Demand June 2, 2026 9:30 pm EIN Presswire The global lysine market is set to grow from US$6.3 Bn in 2026 to US$9.7 Bn by 2033, driven by rising demand for animal protein & efficient feed LONDON, LONDON, UNITED KINGDOM, June 2, 2026 /EINPresswire.com/ -- The global lysine market is …
- Smart pharma is no longer a buzzword: pharma technological breakthroughs at PHARMAP 2026 June 2, 2026 7:51 pm Pharmaceutical Technology In recent years, the context surrounding the pharmaceutical industry has been growing towards digitalisation of processes. Manual operations in pharma are disappearing and have now declined to 1% in 2025. Although this is a major step forward, 69% of …
- 30 Startups To Watch: Startups That Caught Our Eye In May 2026 June 2, 2026 6:12 pm Inc42 With the war in West Asia looming over India’s business environment, May brought a slower, more cautious rhythm to the country’s startup ecosystem. The world’s third-largest startup market spent much of the month in a defensive mode, with listed and late- …